# Study to Test the Effectiveness of a New Treatment for Scalp Psoriasis

> **NCT01368887** · PHASE2 · SUSPENDED · sponsor: **DermiPsor, Ltd.** · enrollment: 160 (estimated)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** DPS-102
- **OTHER:** Vehicle / Placebo
- **DRUG:** Calcipotriol Monotherapy
- **DRUG:** Nicotinamide Monotherapy

## Key facts

- **NCT ID:** NCT01368887
- **Lead sponsor:** DermiPsor, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2013-04
- **Primary completion:** 2013-11
- **Final completion:** 2014-04
- **Target enrollment:** 160 (ESTIMATED)
- **Why stopped:** Sponsor seeking additional financial support before starting the study
- **Last updated:** 2011-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01368887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01368887, "Study to Test the Effectiveness of a New Treatment for Scalp Psoriasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01368887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*